Probiotics and pidotimod face scrutiny for residual immune activation in HIV
A 2026 mini-review finds that probiotics and pidotimod remain investigational for residual immune activation in treated HIV, with heterogeneous studies ...
Tag: pidotimod
POPULAR NEWS
-
Deep learning assesses right ventricle and links findings to cardiovascular outcomes
-
TyHGB index linked to high cardiovascular risk in adults with fatty liver disease
-
Anxiety changes how inflammation marker relates to acute stroke severity
-
Probiotics and pidotimod face scrutiny for residual immune activation in HIV